SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, is driving the sharp rally and renewed attention to its commercial growth. Traders are broadly bullish, with some attributing the move to short covering and anticipating lung-cancer data, while others caution about a pullback or possible share dilution.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data showing slower upper-limb decline after patients switched to deramiocel is driving attention and an after-hours share jump. Many traders view the results as supportive of FDA approval, while others caution that the data may not resolve the agencys concerns over trial analysis and efficacy.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vandas positive Phase 3 results for Hetlioz in delayed sleep-wake phase disorder are driving attention, with the trial meeting its primary endpoint and the company planning to pursue an additional FDA indication. Traders are largely celebrating the readout and potential commercial opportunity, while some caution that approval and revenue impact remain uncertain.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths SPAC merger and Nasdaq listing as XRPN, tied to its planned XRP treasury, are driving attention as traders react to approval and listing milestones alongside a sharp, volatile move. Many are bullish on XRPN and its warrants as leveraged XRP exposure, while others question the valuation and warn of merger-related and de-SPAC risk.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp bounce has traders calling for a breakout and pointing to Zebecs payroll and payments partnerships as a longer-term adoption story. Speculation about Robinhood or BlackRock involvement is unconfirmed, and skeptics question whether the move can hold amid a history of weak follow-through.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion centers on the Trump administrations Iran conflict and uncertain diplomacy, with traders debating its effects on oil and diesel prices and broader market conditions. Political criticism and midterm speculation dominate much of the conversation, alongside a smaller bullish contingent anticipating a squeeze.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is chiefly being discussed as a broad-market, long-term buy-and-hold core, with traders praising diversification and steady accumulation. Others warn that the total-market fund remains exposed to concerns about elevated tech and AI valuations, interest rates, and broader market volatility, while some investors continue to favor buying dips.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Traders are focused on the August PCE inflation report and what it could mean for Treasury yields and the Feds next rate decision, with some expecting cooler data to support a rebound and others bracing for renewed selling. Rising-yield concerns and quarter-end trading are adding to the choppy price action and debate over whether the market will recover or extend its losses.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is being discussed amid volatile oil prices and shifting U.S.-Iran negotiations over the Strait of Hormuz, with traders weighing hopes for de-escalation against continuing supply-disruption risks. Views are split between bearish calls for a pullback as oil cools and bullish arguments that geopolitical risks continue to support energy stocks.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is under pressure amid concerns that Kalshi and Polymarket are intensifying competition and that prediction-market regulation could reshape sports wagering. Bears focus on the competitive threat and spending needs, while bulls cite DKeXs rising trading volumes and continued sportsbook growth as reasons for optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Streetwise

Streetwise Reports